Vanqua Bio
Chicago
About Vanqua Bio
Vanqua Bio is a biotechnology company that discovers and develops next-generation medicines for patients with neurodegenerative diseases. The company's technology platform utilizes human genetics and patient-derived neuronal cells to identify, validate, and clinically translate novel disease pathways associated with lysosomal dysfunction or aberrant activation of the innate immune system.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $130.0M
- Last round: Series Unknown (Jul 2024)
- Website: vanquabio.com
- Phone: 773-360-1673
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/vanqua-bio-7513 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.